Search - tctmd.com

Displaying 81 - 100 of 239

Sort: Relevancy | Date

News Daily News

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

Michael O'Riordan

January 14, 2021

News Conference News AHA 2020

SCAPIS: CTA Finds Silent CAD in 42% of Middle-aged Adults

Shelley Wood

November 13, 2020

News Conference News EAS 2020

Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention

Michael O'Riordan

October 08, 2020

News Daily News

Autopsy Study Finds Most COVID-19 Patients Have Macrophages in Myocardium

L.A. McKeown

October 02, 2020

News Daily News

Postmenopausal Women See Added ASCVD Risk After Complicated Pregnancies

Caitlin E. Cox

September 18, 2020

News Daily News

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Yael L. Maxwell

September 14, 2020

News Conference News ESC 2020

In Long-term, Real-world Data, CABG Bests PCI for Diabetic Patients With MVD

Yael L. Maxwell

September 01, 2020

News Conference News ESC 2020

Trimetazidine Safe but Not Protective Long-term After PCI

Caitlin E. Cox

August 30, 2020

News Conference News ESC 2020

Rhythm Control Cuts First CV Events in Early Atrial Fibrillation: EAST-AFNET 4

Shelley Wood

August 29, 2020

News Daily News

Young Patients With Premature ASCVD Less Likely to Receive Statins, Aspirin

Michael O'Riordan

August 25, 2020

News Conference News SCCT 2020

ISCHEMIA, Patient Age in PROMISE Among Top CT Papers of the Year at SCCT

Yael L. Maxwell

July 20, 2020

News Daily News

Bempedoic Acid Safe, Lowers LDL in Hypercholesterolemia: Pooled RCT Data

Yael L. Maxwell

July 07, 2020

Hope for these hard-to-treat patients: more than half saw ≥ 50% decrease at 24 weeks, regardless of LDL receptor function.

News Conference News ACC 2020

Evinacumab Cuts LDL Cholesterol in Homozygous FH

Yael L. Maxwell

April 01, 2020

News Conference News ACC 2020

Statins May Have Protective Effect on Chemotherapy-Induced Cardiotoxicity

Yael L. Maxwell

March 19, 2020

News Daily News

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

Yael L. Maxwell

March 10, 2020

News Daily News

Type 2 MI Linked to More CV Deaths, Even in Younger Patients

Shelley Wood

March 04, 2020

News Daily News

Long-term Evolocumab Safe, Effective for Familial Hypercholesterolemia Treatment

Yael L. Maxwell

February 12, 2020

News Daily News

Earlier, Longer Interventions Proposed for Optimal Population LDL Cholesterol

Yael L. Maxwell

January 28, 2020

News Daily News

Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL

Michael O'Riordan

January 17, 2020

News Daily News

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Yael L. Maxwell

December 20, 2019

Advertisement

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

SCAPIS: CTA Finds Silent CAD in 42% of Middle-aged Adults

Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention

Autopsy Study Finds Most COVID-19 Patients Have Macrophages in Myocardium

Postmenopausal Women See Added ASCVD Risk After Complicated Pregnancies

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

In Long-term, Real-world Data, CABG Bests PCI for Diabetic Patients With MVD

Trimetazidine Safe but Not Protective Long-term After PCI

Rhythm Control Cuts First CV Events in Early Atrial Fibrillation: EAST-AFNET 4

Young Patients With Premature ASCVD Less Likely to Receive Statins, Aspirin

ISCHEMIA, Patient Age in PROMISE Among Top CT Papers of the Year at SCCT

Bempedoic Acid Safe, Lowers LDL in Hypercholesterolemia: Pooled RCT Data

Evinacumab Cuts LDL Cholesterol in Homozygous FH

Statins May Have Protective Effect on Chemotherapy-Induced Cardiotoxicity

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

Type 2 MI Linked to More CV Deaths, Even in Younger Patients

Long-term Evolocumab Safe, Effective for Familial Hypercholesterolemia Treatment

Earlier, Longer Interventions Proposed for Optimal Population LDL Cholesterol

Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content